Abstract
We highly appreciate the willingness of the authors to reanalyze the Prevention and Observation of Surgical Endpoints (PROSE) dataset reported by Domchek et al. ( 1 ) and the cohort used by Kauff et al. ( 2 ) according to our proposed design ( 3 ), which the authors summarized very well in three points (second sentence in the Correspondence). By using risk-reducing salpingo-oophorectomy (RRSO) as a time-dependent variable in the reanalyses, immortal person-time bias (third point) was avoided in both studies. It remains unclear, however, why in the PROSE reanalysis the observation did not start at the age of DNA testing (second point). In this way, overselection of breast cancer (BC) cases in the non-RRSO group (first point) may still have resulted in an overestimation of BC risk reduction after RRSO (“cancer-induced testing bias”). The original Kauff study was already free of this type of bias. The reanalysis of the Kauff data is now restricted to BRCA1/2 mutation carriers who were unaffected at start of the observation, and also the immortal time bias is avoided. Remarkably, given the relatively short follow-up period after RRSO (2.5 years in the original analysis), the risk estimate remains (statistically nonsignificantly) decreased (hazard ratio [HR] = 0.50, 95% confidence interval [CI] = 0.20 to 1.25).

This publication has 6 references indexed in Scilit: